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Abstract. Insulin stimulates glucose transport in mus- 
cle and adipose tissue by triggering the movement of 
the glucose transporter GLUT-4 from an intracellular 
compartment to the cell surface. Fundamental to this 
process is the intracellular sequestration of GLUT-4 in 
nonstimulated ceils. Two distinct targeting motifs in the 
amino and carboxy termini of GLUT-4 have been pre- 
viously identified by expressing chimeras comprised of 
portions of GLUT-4 and GLUT-l, a transporter iso- 
form that is constitutively targeted to the cell surface, in 
heterologous cells. These motifs-FQQI in the NH  2 ter- 
minus and LL in the COOH terminus-resemble en- 
docytic signals that have been described in other pro- 
teins. In the present study we have investigated the 
roles of these motifs in GLUT-4 targeting in insulin- 
sensitive cells. Epitope-tagged GLUT-4 constructs en- 
gineered to differentiate between endogenous and 
transfected GLUT-4 were stably expressed in 3T3-L1 
adipocytes. Targeting was assessed in cells incubated in 
the presence or absence of insulin by subcellular frac- 
tionation. The targeting of epitope-tagged GLUT-4 was 
indistinguishable from endogenous GLUT-4. Mutation 
of the FQQI motif (F  5 to A 5) caused GLUT-4 to consti- 
tutively accumulate at the cell surface regardless of ex- 
pression level. Mutation of the dileucine motif (t489L  490 
to A489A  49°) caused an increase in cell surface distribu- 
tion only at higher levels of expression, but the overall 
cell surface distribution of this mutant was less than 
that of the amino-terminal mutants. Both NH2- and 
COOH-terminal mutants retained insulin-dependent 
movement from an intracellular to a cell surface locale, 
suggesting that neither of these motifs is involved in the 
insulin-dependent redistribution of GLUT-4. We con- 
clude that the phenylalanine-based NH2-terminal and 
the dileucine-based COOH-terminal motifs play im- 
portant and distinct roles in GLUT-4 targeting in 3T3- 
L1 adipocytes. 
T 
HE mammalian facilitative glucose transporter fam- 
ily consists of six isoforms, referred to as GLUTs  1, 
which  are  highly  homologous  in  both  primary 
amino  acid sequence and predicted secondary topology. 
Heterology between isoforms occurs mainly within the cy- 
toplasmic amino and carboxy termini (Bell et al., 1990; re- 
viewed in James et al., 1993).  GLUT-4 is expressed exclu- 
sively in cardiac and skeletal muscle, and adipose tissue 
(James et al.,  1988, 1989; Birnbaum, 1989; Charron et al., 
1989; Fukumoto et al., 1989). Insulin stimulates the uptake 
of glucose in these tissues to maintain blood glucose ho- 
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1. Abbreviations  used in  this paper:  ECL, enhanced chemiluminescence; 
GLUT,  glucose  transporter  protein  isoform;  HDM,  high-density  mi- 
crosomes; KRP, Krebs-Ringer phosphate; LDM, low-density microsomes; 
M/N,  mitochondria/nuclei;  PM,  plasma  membrane;  TGR,  trans-Golgi 
reticulum. 
meostasis  under  normal  physiological  conditions.  This 
process is largely facilitated by the rapid translocation of 
GLUT-4 from an intracellular compartment to the plasma 
membrane in response to the binding of insulin to its cell 
surface receptor, and is  associated with a  10-30-fold in- 
crease in glucose uptake (Cushman  and Wardzala,  1980; 
Suzuki  and  Kono,  1980).  Immunogold labeling  and EM 
analysis of rat cardiac myocytes and adipocytes has shown 
that in the absence of insulin, GLUT-4 is sequestered pre- 
dominantly within tubulo-vesicular structures clustered ei- 
ther in the trans-Golgi reticulum (TGR) or in the  cyto- 
plasm  (Slot  et  al.,  1991a, b).  With  insulin  treatment,  a 
marked increase in cell surface GLUT-4 labeling (~42% 
of the total) was observed with a corresponding decrease 
in  labeling  within  intracellular  structures  (Slot  et  al., 
1991a,b). 
The intracellular sequestration of GLUT-4 is unique, as 
other isoforms, such as GLUT-l, have a high cell surface 
distribution in the absence of insulin  (Calderhead et al., 
1990; Piper et al.,  1991; Haney et al.,  1991; Hudson et al., 
1992). GLUT-4 is sequestered within intracellular tubulo- 
vesicular structures when expressed in  heterologous cell 
types such as fibroblasts, HepG2 hepatoma and CHO cells 
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1992).  However,  the  insulin-dependent  movement  of 
GLUT-4 to the cell surface is minimal in these cells (Haney 
et al., 1991; Robinson et al., 1992; Verhey et al., 1993). This 
strongly  suggests  that  the  subcellular  targeting  of these 
glucose transporters reflects their heterologous amino acid 
sequences and that factors that regulate their intracellular 
targeting are both shared by many cell types and separate 
from those factors that may be specific to muscle and adi- 
pose cells and that regulate insulin-dependent  transloca- 
tion to the plasma membrane. 
In an attempt to define the relevant targeting domains 
that direct the intracellular sequestration of GLUT-4, chi- 
meric studies have been performed in fibroblasts in which 
reciprocal domains were exchanged between GLUT-4 and 
GLUT-1. These studies  identified  functional  domains in 
both  the  amino  and  carboxy termini,  and  in  transmem- 
brane regions 7 and 8 (Asano et al., 1992; Piper et al., 1992; 
Czech  et  al.,  1993;  Marshall  et  al.,  1993;  Verhey  et  al., 
1993). Site-directed mutagenesis has revealed that phenyl- 
alanine at position 5 in GLUT-4 is a critical component of 
an NH2-terminal targeting motif comprising residues 2-8 
(PSGFQQI) that is "both necessary and sufficient for in- 
tracellular  sequestration"  when  substituted  onto  the  H1 
subunit  of the  asialoglycoprotein  receptor  (Piper  et  al., 
1993).  A dileucine motif at positions 489 and 490 was addi- 
tionally identified as a critical component of the COOH- 
terminal signal for both endocytosis and intracellular se- 
questration of GLUT-4 (Corvera et al., 1994; Verhey and 
Birnbaum, 1994). 
A  potential problem with the above studies is that they 
have been performed in cell types that are not considered 
to  be bona-fide  insulin-sensitive  cells,  and  are  therefore 
unlikely to contain  the cell-specific factors that facilitate 
the  insulin-regulated  translocation  of  GLUT-4  to  the 
plasma membrane. It has remained unclear whether these 
domains  function  to  regulate  GLUT-4  targeting  in  the 
context of an appropriate insulin-responsive cellular envi- 
ronment. In addition, contradictory reports between labo- 
ratories with respect to the targeting of analogous GLUT- 
1/GLUT-4 chimeras suggest that differences in the level of 
chimera expression may influence the resultant targeting 
of these proteins (reviewed in James and Piper, 1994). 
To  address  these  problems  we  have  stably  expressed 
GLUT-4 mutants in 3T3-L1 adipocytes, a cell type that ex- 
hibits insulin-regulatable glucose transport. Because these 
cells express GLUT-4, an epitope tag has been used to distin- 
guish recombinant GLUT-4 from the endogenous GLUT-4. 
We show that  the epitope-tagged GLUT-4 construct be- 
haves  indistinguishably  from endogenous  GLUT-4,  and 
we further show that mutation of either phenylalanine  5 in 
the  NH2-terminal  or  leucine489-1eucine 49°  in  the  COOH- 
terminal domains results in impaired targeting of GLUT-4 
in 3T3-L1 adipocytes. 
Materials and Methods 
Cell Culture 
Murine fibroblasts obtained from the American Type Culture Collection 
(Rockville,  MD) were cultured in DME containing high glucose,  L-gluta- 
mine  and  sodium pyruvate supplemented with 10%  bovine calf serum 
(CSL, Parkville,  Australia). Cells were maintained and passaged as precon- 
fluent cultures at 37°C in a 5% CO2 humidified incubator before differen- 
tiation.  All experiments utilized  adipocytes 10-14 d after initiation of dif- 
ferentiation.  3T3-L1  fibroblasts were induced  to differentiate  3  d  after 
reaching confluence by the addition of DME containing 5% heat-inacti- 
vated FCS (CSL), 4 ~g/ml insulin, 0.25 mM dexamethasone, 0.5 mM 3-iso- 
butyl-l-methylxanthine and 100 ng/ml d-biotin. After 72 h, induction me- 
dium was replaced with fresh FCS/DME containing 4 izg/ml insulin  and 
100 ng/ml d-biotin. 
Construction of Human GLUT-3 Epitope-tagged 
Transporter cDNAs 
Wild-type rat GLUT-4 cDNA cloned into pBluescript (pIRGT) (Piper et 
al.,  1993) was epitope-tagged at the COOH terminus by the addition of 
amino acids 485-496  from human GLUT-3. This construct was generated 
by PCR using the vector T7 primer and an oligonucleotide encompassing 
a  XhoI restriction site,  the  GLUT-3 sequence and  the  overlapping se- 
quence of the GLUT-4 cDNA. The PCR conditions used were identical  to 
those described previously (Piper et al., 1993). The PCR product contain- 
ing the GLUT-3 epitope was digested with BglII-XhoI, and the ~140 bp 
fragment was subcloned into the BglII-XhoI sites of pIRGT to generate 
pTAG. The pFAG construct was generated by removing the XbaI-SacII 
fragment containing the NHz terminus from the F 5 to A 5 mutant described 
previously (Piper et al., 1993) and ligating  into the pTAG backbone. The 
L4SgL  49° to A489A  49° mutant in pIRGT was constructed using a PCR tech- 
nique  described previously (Aim and  Mattick,  1995). This mutant was 
then used as the template DNA in a PCR reaction identical  to that em- 
ployed to generate the pTAG construct. Finally,  the COOH terminus con- 
taining the GLUT-3 epitope and the L489L  49° to A489A4~ mutation were 
subcloned into the BgllI-Xhol sites of plRGT to generate pLAG. All re- 
gions of the cDNA constructs produced by PCR were entirely sequenced. 
To facilitate  insertion of these cDNA constructs into the pMEXneo ex- 
pression vector (kindly  provided by Dr. E. Santos, National Institutes of 
Health, Bethesda, MD) (Benito et al., 1991) for stable transfection, they 
were all removed as XbaLXhoI fragments into a shuttle vector that was 
essentially  pBluescript with a modified multiple cloning site region such 
that the XbaI and XhoI restriction sites were flanked by BamHI and KpnI 
restriction sites, respectively.  Once subcloned into this shuttle vector, the 
cDNA constructs could be removed as BamHI-KpnI fragments and then 
inserted directionally into the pMEXneo vector under the control of the 
MSV-LTR promoter. 
Stable Transfection of cDNA Transporter Constructs 
into 3T3-LI Fibroblasts 
Recombinant GLUT-4 cDNA constructs subcloned into the BamHI and 
KpnI sites of the mammalian expression vector pMEXneo were trans- 
fected into subconfluent 3T3-L1  fibroblasts using the Lipofectamine re- 
agent, according to the manufacturer's protocol (GIBCO BRL, Gaithers- 
burg, MD). Individual neomycin-resistant colonies were selected in media 
containing 0.8 mg/ml G418  (GIBCO BRL) and isolated using glass clon- 
ing rings. Clones were screened as follows. 
lmmunofluorescence microscopy. To  assess clonality  of expression, fi- 
broblasts cultured on ethanol-washed glass coverslips were fixed  in 2% 
paraformaldehyde,  permeabilized,  and  immunolabeled with  antibodies 
specific  for either  GLUT-4 or the  human GLUT-3  epitope  tag  as de- 
scribed previously (Piper et al., 1991, 1992). Primary antibodies were de- 
tected  with FITC-conjugated sheep anti-rabbit secondary antibody (25 
ixg/ml) (The Binding Site,  Birmingham, UK). Coverslips were mounted 
on glass slides as previously described (Piper et al., 1991) and were visual- 
ized with a 63×/1.40 Zeiss oil immersion lens using a Zeiss Axioskop fluo- 
rescence  microscope (Carl  Zeiss, Germany) equipped  with  a  Bio-Rad 
MRC-600  laser confocal imaging system. Images were collected  directly 
using identical  photomultiplier tube, numerical aperture and gain settings. 
Differentiation. Fibroblasts were grown to confluence in 60-mm plates 
and induced to differentiate as described above. Clones in which >90% of 
fibroblasts successfully  differentiated  into mature  adipocytes in  culture 
were maintained and subjected to further analysis. 
Immunoblotting of total cellular membranes. Fibroblasts or adipocytes  cul- 
tured in 60-mm plates were scraped in Hepes buffer (20 mM, pH 7.4) con- 
taining 1 mM EDTA and 250 mM sucrose (HES), lysed using a 1-ml sy- 
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TLA-100.3 rotor (Beckman, Palo Alto, CA, USA) to pellet total cellular 
membranes. Membrane pellets were  resuspended in  1%  SDS  in HES 
buffer and subjected to SDS-PAGE and immunoblotting using antibodies 
specific for either the COOH terminus of GLUT-4 or human GLUT-3. 
This procedure provided an assessment  of the relative expression levels of 
each clone. 
Subcellular Distribution of Transporter Constructs in 
3T3-L1 Adipocytes 
Two separate methods were employed to assess the subcellular distribu- 
tion of recombinant GLUT-4 transporters in 3T3-L1 adipocytes. 
Differential Centrifugation. Subcellular membrane fractions were pre- 
pared by differential centrifugation from transfected adipocytes in basal 
and insulin-stimulated states using a method described in detail previously 
(Piper  et  al.,  1991).  Briefly,  adipocytes  grown in  100-mm plates were 
washed three times with sterile, prewarmed PBS and incubated for 2 h at 
37°C in 10 ml of Krebs-Ringer phosphate (KRP) buffer containing 2% 
BSA and 2.5 mM glucose. Cells were then further incubated for 30 min at 
37°C in either KRP containing 4  Ixg/ml insulin (insulin-stimulated) or in 
KRP with no additions (basal) (2 ×  100-mm plates were used per condi- 
tion). 
All subsequent steps were carried out at 0~°C. The cells were washed 
three times with 5 ml HES buffer and scraped from the plate with a rubber 
policeman in HES containing PMSF (50/~g/ml) and aprotinin (10 ~g/ml) 
(2 ml/plate). Cells were homogenized by 10-12 passages through a Balch 
homogenizer containing a stainless steel ball bearing (diameter 0.2510") 
(Balch et al., 1984). The homogenate was subjected to differential centrif- 
ugation using a previously described protocol (Piper et al., 1991) to gener- 
ate  four  membrane  fractions  designated  as  high-density  microsomes 
(HDM), low-density microsomes (LDM), plasma membranes (PM), and 
mitochondria/nuclei (M/N). Most of our studies were performed using the 
PM and LDM fractions because these fractions are enriched in cell surface 
membrane and membranes encompassing the intracellular GLUT-4 com- 
partment, respectively (Piper et al., 1991).  Membranes were resuspended 
in HES buffer and stored at -20°C. The protein yields for each of the four 
subcellular membrane fractions recovered from 3T3-L1 adipocytes by dif- 
ferential  centrifugation were  not  significantly different from those de- 
scribed previously (Piper et al., 1991).  Furthermore, we did not observe 
significant variance in these protein yields between individual clonal cell 
lines. 
Plasma Membrane Lawn Assay. The subceUular distribution of recombi- 
nant transporters was also assessed by immunofluorescence labeling of 
plasma membrane fragments prepared from basal and insulin-stimulated 
adipocytes as described previously (Robinson and James, 1992; Robinson 
et al., 1992).  Briefly, adipocytes were grown on glass coverslips and soni- 
cated using a probe sonicator (Kontes, Vineland, NJ) to generate a lawn 
of PM fragments that remained attached to the glass. These fragments 
were then immunolabeled with either polyclonal antibodies specific for ei- 
ther GLUT-4 or the human GLUT-3 epitope-tag. Coverslips were visual- 
ized and imaged using a confocal laser scanning immunofluorescence mi- 
croscope as described above. 
Electrophoresis and Immunoblotting 
Equivalent amounts of protein from total cellular membranes (20 p~g) or 
subceUular membrane fractions (10 }xg) were subjected to SDS-PAGE us- 
ing 10 or 12% polyacrylamide resolving gels. Proteins were electrophoret- 
ically transferred to supported nitrocellulose membranes (Amersham, Lit- 
tle Chalfont, Buckinghamshire, UK) and immunoblotted with polyclonal 
antibodies specific for the COOH termini of GLUT-4 (R820), GLUT-1 
(R493), and human GLUT-3 (R1697), respectively. The anti-peptide poly- 
clonal antibodies specific for the COOH terminus of GLUT-1  (R493), 
GLUT-4 (R820) and the 12 carboxy-terminal residues of human GLUT-3 
(R1697) have been characterized and described previously (James et al., 
1989; Piper et al., 1991; Harris et al., 1992). R493 and R1697 were affinity- 
purified against peptide  antigen covalently coupled to a  Sulfolink Cou- 
pling Gel  column according to  the manufacturer's instructions (Pierce 
Chem. Co., Rockford, IL). Primary antibodies were detected by probing 
with HRP-conjugated donkey anti-rabbit secondary antibody diluted 1: 
10,000  and blots developed using the technique of enhanced chemilumi- 
nescence  (ECL)  according  to  the  manufacturer's instructions  (Amer- 
sham). Autoradiograms were quantitated using a Model GS-670 Imaging 
Densitometer (Bio-Rad Labs., Richmond, CA). The level of recombinant 
GLUT-4 at the PM with insulin was nominally assigned a  value of 1 in 
these studies to  normalize  between  individual determinations  and  be- 
tween recombinant constructs expressed by different clones. 
Protein Assays 
The protein concentrations of total cellular membranes and subcellular 
membrane fractions prepared as above were determined using the bicin- 
choninic acid assay (Pierce Chem. Co.) according to the manufacturer's 
instructions. 
Results 
Targeting of Epitope-tagged GLUT-4 
The constructs analyzed in this study are summarized in 
Fig. 1. To assess the contribution of phenylalanine at posi- 
tion  5  or  the  leucine  pair  at  positions  489  and  490  to 
GLUT-4 targeting in 3T3-L1 adipocytes, it was necessary 
to include a foreign epitope in the GLUT-4 eDNA. Rather 
than introduce a foreign sequence at an intervening loca- 
tion within GLUT-4, an epitope tag was introduced at the 
extreme carboxy terminus in  an attempt to preserve the 
overall structure of the protein. This protein reacted with 
both  monoclonal  (1F8,  data  not  shown)  and  polyclonal 
(R820) anti-GLUT-4 COOH-terminal antibodies, and could 
be  uniquely  distinguished  from  endogenous  wild-type 
GLUT-4 with a polyclonal anti-human GLUT-3 antibody 
(R1697)  (see below).  Several criteria were used to show 
that the inclusion of this epitope did not disrupt the native 
targeting  of GLUT-4. The targeting of the  recombinant 
epitope-tagged GLUT-4 protein, referred to here as TAG, 
was indistinguishable  from wild-type GLUT-4 expressed 
in 3T3-L1 fibroblasts by stable transfection (Haney et al., 
1991).  Confocal laser immunofluorescence microscopy of 
1  5  489 490  509 
NH2,  ~  []  m,mm  r~l-eOOH  TAG 
1  S  489 49o  5o9 
NH2"I  B  ""--  k~'COOH  FAG 
1  5  4~ 490  509 
NH2.  I  []  .,lr.~  F~OOOH  LAG 
Figure 1.  Summary of the recombinant GLUT-4 constructs used 
in these studies. A  foreign epitope encompassing the carboxy-ter- 
minal 12-amino acid residues from human GLUT-3 (shaded)  was 
engineered  as an additional  tag at  the 3'  end  of the full-length 
GLUT-4  cDNA. The positions at which site-directed mutagene- 
sis was performed  are shown in black. Amino  acid residues are 
represented using the single letter code. 
Marsh et al. GLUT-4 Targeting in Adipocytes  1083 Figure 2.  Localization of TAG in stably transfected 3T3-L1  cells. (A) Immunolocalization of TAG in stably-transfected 3T3-L1  fibro- 
blasts by confocal immunofluorescence microscopy. Cells were fixed, permeabilized, and labeled with an  antibody specific for the 
COOH terminus of GLUT-4 (R820) and FITC-conjugated sheep anti-rabbit antibody. Shown are fibroblast clones TAG3B1 (left) and 
TAG2D5 (right). Images were collected, adjusted for brightness and contrast and printed using identical conditions. (B and C) Subcellu- 
lar distribution of wild-type GLUT-4 and epitope-tagged recombinant GLUT-4 (TAG) in basal (-) and insulin-stimulated (+) 3T3-L1 
adipocytes. In B, subcellular membrane fractions (10 Izg) were prepared by differential centrifugation and subjected to SDS-PAGE, 
electrophoretically transferred to nitrocellulose membranes and immunoblotted with antibodies specific for the COOH  terminus of 
GLUT-4 (R820), the COOH terminus of GLUT-1 (R493), or for the human GLUT-3 epitope tag (R1697).  Signals were detected by en- 
hanced chemiluminescence (ECL). (C) Immunofluorescence labeling of PM lawns prepared from naive (top) or TAG-transfected (bot- 
tom) 3T3-L1  adipocytes incubated in the absence (left) or presence (right)  of insulin for 15 rain at 37°C. Plasma membrane fragments 
prepared from untransfected or TAG-transfected adipocytes were immunolabeled with either GLUT-4- or human GLUT-3-specific 
antibodies, respectively. Bars, 50 ~m. 
fibroblasts (Fig. 2 A) and immuno-EM of adipocytes (data 
not  shown)  revealed that  TAG  was  localized to  tubulo- 
vesicular elements that were either clustered in the TGR 
or in the cytoplasm. 
Moreover,  the  targeting of TAG  was indistinguishable 
from  endogenous  GLUT-4  in  3T3-L1  adipocytes. In  the 
absence of insulin, TAG was excluded from the PM frac- 
tion and was located predominantly within a vesicle popu- 
lation designated LDM fraction (Fig. 2 B), which has pre- 
viously  been  shown  to  be  enriched  in  the  intracellular 
GLUT-4 compartment in adipocytes (Simpson et al., 1983; 
Piper et al., 1991).  Insulin treatment resulted in a  signifi- 
cant increase in TAG levels in the PM fraction, with a cor- 
responding decrease in the levels of TAG in the intracellu- 
lar LDM. A  more accurate assessment of the magnitude of 
the insulin-dependent movement of both TAG and endog- 
enous GLUT-4 to the cell surface was obtained using the 
PM lawn assay (Fig. 2 C). This procedure generates highly 
purified PM fragments attached to glass coverslips (Rob- 
inson et al., 1992)  and provides a  more sensitive index of 
insulin action. PM fragments isolated from basal cells ex- 
hibited  very  low  levels  of  either  TAG  or  endogenous 
GLUT-4 labeling (Fig. 2  C, left).  A  5-10-fold increase in 
labeling for TAG  and  GLUT-4  was  evident in  PM  frag- 
ments prepared from insulin-treated adipocytes (Fig. 2  C, 
right). 
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cell lines despite  marked differences in TAG expression 
levels between different clones (see below). As an internal 
control for the integrity of the  differential centrifugation 
procedure,  all  fractions  were  routinely  immunoblotted 
with an anti-GLUT-1 antibody.  Consistent with previous 
studies (Calderhead et al., 1990; Piper et al., 1991), GLUT-1 
had a high cell surface distribution in comparison to either 
TAG  or  endogenous  GLUT-4 in  the  absence  of insulin 
(Fig. 2 B). 
Expression of GLUT-4 Targeting Mutants in 
3T3-L1  Cells 
Clones  were  selected  for  further  study  based  upon  the 
level of recombinant protein expressed and their ability to 
undergo  differentiation  from fibroblasts  into  adipocytes 
following transfection  (Fig.  3). Total cellular membranes 
from each  clone  were  immunoblotted  with  an  antibody 
specific for the GLUT-4 carboxy terminus to quantify the 
total  level  of  recombinant  transporter  plus  endogenous 
GLUT-4  expressed  (Fig.  3,  top).  Clones  were  classified 
into two broad categories: low expressors, in which total 
GLUT-4 expression was at a  level comparable to that of 
endogenous GLUT-4 in untransfected adipocytes, and high 
expressors, where total expression was greater than four- 
fold higher than for wild-type GLUT-4 expressed by 3T3- 
L1  adipocytes. To quantify relative expression of the re- 
combinant  transporters  independently  of  endogenous 
GLUT-4, total cellular membranes were  immunoblotted 
with the human GLUT-3 antibody (Fig. 3, bottom). 
In the case of TAG, its intracellular sequestration in the 
absence of insulin was maintained, irrespective of expres- 
sion level. Despite a fourfold difference in expression level 
between TAG clones 3B1  and  2D5,  the  intraceUular  se- 
questration of TAG in both of these clonal cell lines was 
similar to that observed for wild-type GLUT-4. In the ab- 
sence of insulin  stimulation, PM fragments isolated from 
both TAG clone adipocytes exhibited low levels of label- 
ing similar to that observed for wild-type GLUT-4 (Fig. 2 
C). Furthermore,  the  effect of insulin  on the  subcellular 
distribution of TAG was similar over this range of expres- 
sion (Fig. 4). However, it is noteworthy that the labeling of 
PM  fragments isolated  from clone  TAG2D5  adipocytes 
cultured in the presence of insulin was significantly lower 
than for insulin-treated TAG3B1 PM fragments (not shown). 
Targeting of the Phe to Ala Mutant (FAG) 
in Adipocytes 
In  agreement  with  previous  studies  (Piper  et  al.,  1993), 
mutation of F 5 to A s within the amino terminus of epitope- 
tagged GLUT-4 (FAG) resulted in  a  marked increase in 
cell surface accumulation of the transporter. In 3T3-L1 fi- 
broblasts, an increase in cell surface staining was apparent 
for clone FAG1D1  (not shown)  and FAG3C2 fibroblasts 
compared to cell lines expressing TAG as determined by 
confocal immunofluorescence microscopy (Fig. 5 A). FAG 
was also immunolocalized to a  perinuclear region similar 
to that observed for TAG in 3T3-L1 fibroblasts (Fig. 5 A). 
Despite a  level of expression only marginally lower than 
FAG3C2, we were unable to visualize cell surface labeling 
of FAG2C5 fibroblasts using immunofiuorescence micros- 
copy. However, as previously described by Griffiths et al. 
(1993),  this may reflect an artifact of this  technique  that 
arises because low labeling of diffuse surfaces such as the 
plasma membrane is  much more  difficult  to  detect  than 
low but concentrated labeling of intracellular organelles. 
The subcellular distribution  of FAG and  GLUT-1 was 
assessed  by immunoblotting  subcellular  membrane frac- 
tions prepared from the differentiated cell lines with anti- 
Figure 3.  Relative expression levels of transfected GLUT-4 con- 
structs  in  3T3-LI  adipocyte  clones.  Total  cellular  membranes 
were isolated from individual 3T3-LI cell lines. Samples (20 Ixg of 
membrane protein) prepared from each clone were subjected to 
SDS-PAGE  and  immunoblotted  using  antibodies  specific  for 
COOH terminus of GLUT-4 (R820, top) or the human GLUT-3 
epitope-tag  (R1697,  bottom).  Autoradiograms  were quantitated 
by densitometry and the results expressed as arbitrary units to as- 
sess the relative levels of endogenous plus transfected  GLUT-4 
and exogenous transporter alone expressed by each clone. Clones 
were  classified into  two  broad  categories based  upon  the  total 
level  of  GLUT-4  expression  relative  to  endogenous  GLUT-4 
expressed by wild-type 3T3-L1 adipocytes. High expressor clones 
included  TAG3B1, FAG1D1,  and  LAG1A5.  Adipocyte clones 
TAG2D5, FAG3C2, FAG2C5, LAGID3, LAG1B6, and LAGIA4 
were classified as low expressors. 
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Figure 4.  Subcellular distribution  of epitope-tagged recombinant 
GLUT-4 (TAG) expressed at low (TAG2D5) or high (TAG3B1) 
levels in basal (-) and insulin-stimulated  (+) 3T3-L1 adipocytes. 
The combined results  of multiple  independent differential  cen- 
trifugation  experiments immunoblotted with an antibody to the 
human  GLUT-3 epitope tag and  quantitated  by densitometry 
were plotted for basal (-) and insulin-stimulated  (+) adipocytes. 
Values are the means +_ SEM (arbitrary units/ixg protein). 
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Figure 5.  Localization of FAG in stably transfected 3T3-L1 cells. (A) Immunolocalization of FAG in stably transfected 3T3-L1 fibro- 
blasts  by confocal immunofluorescence microscopy. Cells  were fixed,  permeabilized,  and labeled  with  an antibody specific  for the 
COOH terminus of GLUT-4 (R820) and FITC-conjugated sheep anti-rabbit antibody. Shown are fibroblast clones FAG3C2 (left) and 
FAG2C5 (right).  Images were collected, adjusted for brightness and contrast and printed using identical conditions. (B-D): Subcellular 
distribution of epitope-tagged recombinant GLUT-4 (FAG) expressed at high (FAG1D1) or low (FAG3C2 and FAG2C5) levels  in 
basal (-) and insulin-stimulated  (+) 3T3-L1 adipocytes. (B) Subceltular membrane fractions (10 Ixg) prepared by differential centrifu- 
gation were subjected to SDS-PAGE, electrophoretically transferred to nitrocellulose membranes and immunoblotted with either an af- 
finity-purified antibody specific  for the human GLUT-3 epitope tag (R1697,  top) or an antibody specific  for the COOH terminus of 
GLUT-1 (R493, bottom).  Signals were detected by ECL. (C) The combined results of multiple independent differential centrifugation 
experiments were quantitated by densitometry and plotted for basal (-) and insulin-stimulated  (+) adipocytes. Values are the means --+- 
SEM (arbitrary units/txg protein). (D) Immunofluorescence labeling of PM lawns prepared from FAG-transfected 3T3-L1 adipocytes 
incubated in the absence (left) or presence (right) of insulin for 15 min at 37°C. Plasma membrane fragments prepared from FAG-trans- 
fected adipocytes were immunolabeled with the human GLUT-3 antibody. Bars: (A and D) 50 ~xm. 
bodies specific for the human GLUT-3 epitope tag (top), 
or  GLUT-1  (bottom)  (Fig.  5  B).  Irrespective  of the  cell 
line or the expression level of recombinant protein exam- 
ined, FAG exhibited  a  substantial  targeting defect in adi- 
pocytes. Both differential centrifugation (Fig. 5 B) and im- 
munolabeling of PM lawns (Fig. 5 D) revealed  a  marked 
accumulation of FAG in plasma membranes isolated from 
non-insulin-stimulated  cells. The difference in the subcel- 
lular  distribution  of FAG  and  TAG  is  clearly  demon- 
strated by comparing the PM/LDM ratio for each protein, 
which provides an index of the intracellular  sequestration 
of transporters  (see Fig. 7).  This ratio was extremely low 
for TAG (0.33 ±  0.09), reflecting a high degree of intracel- 
lular  sequestration.  In  contrast,  the  PM/LDM  ratio  was 
seven- to eightfold higher for FAG (2.46  -*- 0.38), reflect- 
ing the high level of FAG at the plasma membrane in com- 
parison  to the intracellular  vesicle  pool.  It is noteworthy 
that  the  subcellular  distribution  of  GLUT-1  in  FAG- 
expressing clones was not significantly different from that 
seen in TAG-expressing clones, providing a useful internal 
control for the differential centrifugation procedure. 
Despite  the  accumulation  of FAG  at  the  cell  surface, 
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movement out of the LDM and to the plasma membrane 
fractions, although this was much less than observed for ei- 
ther TAG or wild-type GLUT-4 (Figs. 5, B and C). No visi- 
ble staining of plasma membrane fragments in PM  lawns 
prepared from either FAG3C2 or FAG2C5 was observed 
with the antibody specific for the epitope tag, due to the low 
levels of recombinant protein expressed by these clones. 
Targeting of the Dileucine Mutant (LAG) in Adipocytes 
Four clonal cell lines expressing LAG were isolated and 
used  for  subsequent  study.  These  clones  were  selected 
based  upon  the  level  of LAG  expression,  which  varied 
over a  similar  range  to  that  observed in  the  TAG  and 
FAG clones (see Fig. 3). In addition, the differentiation ef- 
ficiency of these clones was very high as determined by the 
high percentage  (>90%)  of cells that exhibited  multiple 
lipid droplets at >4 d after differentiation. In the undiffer- 
entiated state, high cell surface staining was clearly evident 
in the LAG clone (LAG1A4) by immunofluorescence mi- 
croscopy  (Fig.  6  A).  However,  as  was  the  case  for  the 
lower expressing FAG clones, little if any detectable cell 
surface staining was evident in low expressing LAG fibro- 
blasts (LAGIB6) (Fig. 6 A). All stably-transfected LAG- 
expressing fibroblasts exhibited  a  perinuclear  pattern  of 
staining  similar  to  the  pattern  described  for  TAG  and 
FAG (Fig. 6 A). 
To further define the targeting of the dileucine mutant 
extensive  experimentation  was  performed following dif- 
ferentiation of each of the clones into adipocytes. The sub- 
cellular  distribution  of LAG and  GLUT-1  in  a  high  ex- 
pressing LAG adipocyte clone (LAG1A5, i.e., LAGhigh), 
and  in two adipocyte clones  exhibiting low levels of ex- 
pression (LAGID3 and LAG1B6, i.e., LAG  l°w) are shown 
in Fig. 6 B. The two distinct subcellular fractionation tech- 
niques, that of differential centrifugation (Fig. 6 B) and la- 
beling of PM lawns (Fig. 6 D), demonstrated that at low 
expression levels LAG was segregated between the intra- 
cellular compartment and the plasma membrane, in unstim- 
ulated adipocytes, to the same extent as TAG or wild-type 
GLUT-4 (Fig. 2, B and C). In contrast, LAG accumulated 
at the plasma membrane in the absence of insulin in done 
LAG1A5,  in  which  the  expression  of LAG  was  higher 
than in any of the other three LAG clones studied. This 
targeting difference is most clearly evident by comparing 
the PM/LDM  ratios that were quantified  based on frac- 
tionation of non-insulin-stimulated cells. In the case of the 
low expressors (LAGID3 and LAGIB6) the combined ra- 
tio (0.32  +  0.06) was not significantly different compared 
to TAG (0.33  -  0.09). The ratio was significantly higher, 
however, in clone LAG1A5  (1.34  +- 0.17), indicating the 
high  cell  surface  expression  of LAG  expressed  by  this 
clone. In addition, the PM/LDM ratio for LAGIA5 is not 
dissimilar to the ratio observed for GLUT-1 (1.26 -+ 0.08). 
These  data confirmed the staining patterns visualized in 
PM lawns prepared from basal adipocyte clones with ei- 
ther low-moderate (LAG1A4)  or high  (LAG1A5) levels 
of expression (Fig. 6 D). 
The distribution of LAG in adipocyte clones expressing 
LAG at lower levels (LAG1D3 and LAG1B6) following 
insulin  stimulation  was  indistinguishable  from  TAG  or 
wild-type GLUT-4 (Fig. 6, B  and C). In both cases there 
was a significant shift in the distribution of LAG from the 
LDM fraction to  the  plasma membrane. Whereas  there 
was an accumulation of LAG at the cell surface in clone 
LAG1A5 in the absence of insulin, there was still a signifi- 
cant movement of LAG from the LDM to the PM. How- 
ever, in view of the high cell surface distribution of LAG 
in this clone in the basal state, the net magnitude of the in- 
sulin effect at the PM was reduced. The insulin-stimulated 
increase  in  labeling  observed  in  PM  fragments  isolated 
from clone LAG1A4 (Fig. 6 D, bottom right) was not sig- 
nificantly  different  from  either  wild-type  GLUT-4  or 
TAG.  PM  lawns  isolated  from  clones  LAGID3  and 
LAGIB6 and  immunolabeled with the  antibody specific 
for the human  GLUT-3 epitope tag could not be visual- 
ized. 
Discussion 
In this study, our goal was to characterize the role of two 
major GLUT-4 targeting motifs in insulin-sensitive cells. 
Epitope-tagged  GLUT-4  constructs,  in  which  mutations 
were made at either the phenylalanine residue at position 
5  (FAG)  or  the  leucine  residues  at  positions  489-490 
(LAG), were stably expressed in 3T3-L1 adipocytes. FAG 
accumulated at the plasma membrane in the absence of in- 
sulin, irrespective of its expression level, whereas LAG ac- 
cumulated at the plasma membrane only when the mutant 
was  overexpressed  at  levels  that  were  fourfold  endoge- 
nous GLUT-4 levels. Despite these defects in basal target- 
ing, an insulin-dependent movement out of the intracellu- 
lar  fraction  was  still  evident  for  both  LAG  and  FAG 
suggesting that neither the FQQI nor the LL motifs play a 
direct role in the insulin-regulated movement of GLUT-4 
to the plasma membrane. These results suggest that both 
the NH2- and  COOH-terminal targeting motifs play im- 
portant yet functionally distinct roles in GLUT-4 targeting 
in adipocytes. 
The strategy employed in this study was designed to ad- 
dress some of the potential conflicts that have arisen from 
previous  GLUT-4  targeting  studies  (reviewed  in  James 
and Piper, 1994).  We have employed a stable expression 
plasmid, pMex, to express our constructs in 3T3-L1 cells 
(Benito et al., 1991).  This cell line provides a useful model 
for these studies as it is possible to obtain stable transfec- 
tants that differentiate into highly insulin-responsive adi- 
pocytes. The pMex vector achieves a  level of expression 
that approximates endogenous GLUT-4 levels expressed 
in 3T3-L1 adipocytes (Fig. 3). Such considerations are im- 
portant,  as one of the major variables between previous 
GLUT-4 targeting studies was the level of expression ob- 
tained for recombinant transporters due to the use of dif- 
ferent expression systems (Asano et al., 1992; Piper et al., 
1992; Czech et al., 1993; Verhey et al., 1993). This may be 
critical as it has been shown that the overexpression of en- 
dosomal/TGR proteins  may saturate  intracellular  reten- 
tion  mechanisms  in  mammalian cells  and  thus  severely 
complicate the interpretation of results (Wong and Hong, 
1993;  Reaves and Banting,  1994).  We have analyzed the 
targeting of recombinant proteins in several stably trans- 
fected clonal adipocytes to examine the effects of different 
expression levels  (Fig.  3).  Furthermore,  we  utilized  two 
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Figure 6. Localization of LAG in stably-transfected 3T3-L1  cells. (A) Immunolocalization of LAG constructs in stably-transfected 3T3- 
L1 fibroblasts by confocal immunofluorescence microscopy. Cells were fixed, permeabilized, and labeled with an antibody specific for 
the COOH terminus of GLUT-4 (R820) and FITC-conjugated sheep anti-rabbit antibody. Shown are fibroblast clones LAG1A4 (left) 
and LAG1B6 (right). Images were collected, adjusted for brightness and contrast and printed using identical conditions. (B-D) Subcel- 
lular distribution of epitope-tagged recombinant GLUT-4 (LAG) expressed at low (LAG1D3, LAGIB6, LAG1A4) or high (LAGIA5) 
levels in basal (-) and insulin-stimulated (+) 3T3-L1  adipocytes. (B) Subcellular membrane fractions (10 Ixg) prepared by differential 
centrifugation were subjected to SDS-PAGE, electrophoretically  transferred to nitrocellulose membranes and immunoblotted with ei- 
ther an affinity-purified  antibody specific for the human GLUT-3 epitope tag (R1697, top) or an antibody specific for the COOH termi- 
nus of GLUT-1 (R493, bottom). Signals were detected by ECL. (C) The combined results of multiple independent differential centrifu- 
gation experiments were quantitated by densitometry and plotted for basal (-) and insulin-stimulated (+) adipocytes. Values are the 
means +  SEM (arbitrary units/ixg protein). (D) Immunofluorescence labeling of PM lawns prepared from LAG-transfected 3T3-L1  ad- 
ipocytes incubated in the absence (left)  or presence (right)  of insulin for 15 rain at 37°C. Plasma membrane fragments prepared from 
LAG-transfected adipocytes were immunolabeled with the human GLUT-3 antibody. Shown are adipocyte clones LAGIA5 (top) and 
LAG1A4 (bottom). Bars: (A and D) 50 rLm. 
separate  subcellular fractionation  schemes,  that  are  well 
established for these cells, and which enable unambiguous 
analysis of glucose transporter targeting. This was funda- 
mental to these studies since the primary method used to 
assess GLUT-4 targeting by a  variety of groups has been 
immunofluorescence microscopy (Czech et al., 1993; Ver- 
hey et al., 1993; Corvera et al., 1994). Immunofluorescence 
localization of our constructs in stably-transfected 3T3-L1 
fibroblasts failed to clearly resolve the intracellular distri- 
bution of these recombinant proteins (Figs. 2 A, 5 A, and 6 
A). As noted by others previously, this technique is prone 
to artifact; similar ambiguous results have been attributed 
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Figure  7.  The  PM/LDM  ra- 
tios  of  recombinant  trans- 
porter constructs in basal ad- 
ipocytes  were  calculated 
from data obtained for all in- 
dividual clones over multiple 
separate  experiments.  Data 
from experiments with either 
TAG  or  FAG-transfected 
3T3-L1  adipocyte  clones 
were pooled and considered 
as representative of a pheno- 
type distribution for TAG or 
FAG respectively, due to the 
consistency of results for individual clones irrespective of their 
levels of expression. TAG values were calculated from 10 sepa- 
rate determinations for clones TAG3B1  and TAG2D5.  The re- 
sults  of  five  separate  determinations  for  clones  FAG1D1, 
FAG3C2 and FAG2C5 are shown for FAG. Values presented as 
the LAG  l°w phenotype were calculated from six separate deter- 
minations  for clones  LAG1D3  and  LAG1B6.  LAG  high values 
were  calculated  from  four  separate  determinations for  clone 
LAG1A5. Values are shown as the means +_ SEM for a minimum 
of four independent determinations. 
to both differences in expression levels and to inadequate 
resolution using this technique  (Asano et al.,  1992;  Hud- 
son et al., 1992;  Griffiths et al., 1993; Verhey et al., 1993). 
The use of a  nondisruptive  epitope tag was preferred to 
undertaking a chimeric approach, as recombinant chime- 
ras  may  alter  conformational  determinants  essential  to 
proper  GLUT-4 targeting.  Our  results  indicate  that  the 
targeting of epitope-tagged GLUT-4 (TAG) over a  wide 
range of expression levels was indistinguishable from that 
of wild-type  GLUT-4, as reported  here  and  in  previous 
studies (Calderhead et al., 1990; Holman et al., 1990; Piper 
et  al.,  1991;  Robinson  and  James,  1992).  Similar  results 
were obtained in several different clones expressing TAG 
at levels approximately two- to sixfold greater than endog- 
enous GLUT-4 (Fig. 2). 
Our assessment of the subcellular distribution of recom- 
binant  GLUT-4 transporters clearly shows  that both the 
NH2-terminal  phenylalanine  and  COOH-terminal  dileu- 
cine motifs function in the targeting of GLUT-4 in 3T3-L1 
adipocytes. Mutation of either of these motifs to alanine re- 
sulted in a marked accumulation of recombinant GLUT-4 
at the cell surface in an insulin-independent  manner. This 
resulted in impaired insulin action by default because the 
index  of this  phenomenon  involves accumulation  of the 
protein at the plasma membrane. However, both FAG (F  5 
to A) and LAG (L489L  49° to AA) retained  their insulin- 
dependent movement out of the intracellular LDM vesicle 
fraction suggesting that neither of these motifs directly reg- 
ulates the insulin-dependent translocation of GLUT-4 per 
se. Hence, we propose that the information that encodes 
the insulin regulatability of GLUT-4 must be located else- 
where in the protein. 
The observation that LAG accumulated at the cell sur- 
face only when overexpressed, whereas FAG accumulated 
at the cell surface irrespective of expression level, suggests 
that  these  two  domains  may  regulate  distinct  targeting 
events. The fact that the LL mutant had a wild-type sub- 
cellular distribution at low expression suggests that under 
these conditions other targeting motifs must compensate 
for this mutation  This could include either the NH2-termi- 
nal FQQI motif or other motifs elsewhere in the protein. 
Alternatively,  the  dileucine  residues  may comprise  only 
part of a larger motif, in which case mutation of these resi- 
dues  to  alanine  might not greatly disrupt  its overall ter- 
tiary structure.  It is important to note that the dileucine 
signal is flanked by the phosphorylation site in  GLUT-4 
(Lawrence et al., 1990), and it will be of interest to deter- 
mine if mutation of t489L  490 tO AA abrogates phosphoryla- 
tion of the transporter in an expression-dependent man- 
ner.  It  has  been  postulated  previously that  the  relative 
affinities of aromatic- and  dileucine-based  motifs for ei- 
ther internalization or intracellular sorting functions could 
be altered either by phosphorylation-dephosphorylation, 
or  by other  posttranslational  modifications  (reviewed in 
Trowbridge et al., 1993). That FAG exhibited a high cell 
surface distribution irrespective of its expression level sug- 
gests that other motifs were unable to compensate for this 
defect. This implies that this motif may be intimately in- 
volved in regulating the movement of GLUT-4 between 
the cell surface and endosomes or vice versa. 
The  dependence  of  LAG  targeting  upon  expression 
level may account for our inability to detect a role for the 
GLUT-4 carboxy terminus on intracellular targeting in the 
past  (Piper  et al.,  1992,  1993).  Previously, we have used 
Sindbis virus to express chimeras comprised of portions of 
GLUT-1 and GLUT-4 in CHO cells. Only chimeras con- 
taining the NH2 terminus of GLUT-4 targeted in a manner 
similar to GLUT-4. These results are consistent with the 
present studies given a moderate level of expression of the 
chimeric  constructs.  However,  it  remains  unclear  why 
other groups have been unable to demonstrate an effect of 
the NH2 terminus on GLUT-4 targeting, particularly since 
we have observed this effect in a variety of different cell 
lines and using different modes of cDNA expression. 
What is the function of these targeting domains in the 
intracellular  trafficking of GLUT-4? While  we  have not 
specifically addressed this question in the present studies, 
it  is possible  to speculate  based  on previous work.  It is 
known,  largely from EM  studies,  that  GLUT-4 recycles 
between the cell surface and intracellular tubules and vesi- 
cles via the classical coated pit/endosomal pathway (Slot et 
al., 1991a, b; Robinson et al., 1992).  In the absence of insu- 
lin, GLUT-4 appears to be withdrawn from this recycling 
system (Slot et al.,  1991b)  and this is consistent with the 
fact that GLUT-4 is actively retained within the cell (Hol- 
man et al., 1990). The nature of the intracellular compart- 
ment in which GLUT-4 is stored is poorly defined but it is 
thought  to  be  somewhat  specialized  (reviewed  in  Birn- 
baum, 1992 and James and Piper, 1994), and so the target- 
ing of GLUT-4 to this compartment may confer its unique 
insulin regulation. The NH2- and COOH-terminal GLUT- 
4 targeting motifs were first identified by studying the dis- 
tribution  of  GLUT-I/GLUT-4  chimeras  in  fibroblasts 
(Piper et al., 1992; Czech et al., 1993; Marshall et al., 1993; 
Verhey et al., 1993).  From these studies it was shown that 
when added to GLUT-1 either the NH2 or COOH termi- 
nus of GLUT-4 could, to a certain extent, recapitulate the 
unique  intracellular  sequestration  of the  entire  GLUT-4 
protein.  Both of these motifs have been reasonably well 
characterized in fibroblasts and CHO cells and have been 
shown  to  have  the  capacity  to  regulate  internalization 
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(1994) demonstrated that the amino terminus of GLUT-4, 
when substituted for the transferrin receptor cytoplasmic 
domain, functions to promote the efficient internalization 
of the protein from the cell surface in a manner critically 
dependent upon the residue at position 5. In addition, mu- 
tation of F 5 to A  caused a  marked reduction in GLUT-4 
targeting to cell surface clathrin-coated pits in CHO cells 
(Piper  et  al.,  1993).  Furthermore,  these  motifs resemble 
motifs found in many other endosomal proteins. Thus, it is 
tempting to conclude that the predominant role of these 
domains  is  to  regulate  GLUT-4  internalization.  While 
these domains may play a role in GLUT-4 internalization, 
kinetic analysis of different transporters in 3T3-L1  adipo- 
cytes indicate  that there is not a  significant difference  in 
the  internalization rates between  GLUT-1  and  GLUT-4 
(Yang and Holman, 1993).  Thus, this suggests  that these 
motifs must regulate additional functions in the intracellu- 
lar sorting of GLUT-4. This most likely involves either the 
retention of GLUT-4 in endosomes or its sorting into the 
specialized compartment that is withdrawn from the endo- 
somal system.  Consistent with  this type  of model, it  has 
been shown that aromatic residue-based motifs and dileu- 
cine motifs play distinct though functionally similar roles 
in other proteins. For instance, the cytoplasmic tail of the 
cation-independent mannose 6-phosphate/IGF II receptor 
(CI-MPR)  contains  an  aromatic  residue-based  motif 
(YKYSKV)  that  primarily  regulates  internalization  but 
contributes additionally,  although not significantly,  to in- 
tracellular Golgi sorting, and a dileucine based motif adja- 
cent to the aromatic motif that regulates cycling between 
the  Golgi  and  late  endosomes  (Johnson  and  Kornfeld, 
1992).  Disruption  of  the  aromatic-based  motif critically 
disrupts internalization of the receptor resulting in its ac- 
cumulation at the cell surface, whilst having only a slight 
effect  upon  intracellular  sorting  (Lobel  et  al.,  1989; 
Johnson and Kornfeld, 1992). Conversely, mutation of the 
dileucine  residues  abrogates intracellular sorting without 
altering internalization of the receptor (Johnson and Korn- 
feld, 1992). 
Defects in GLUT-4  translocation are likely to occur in 
insulin-resistant disease states such as non-insulin-depen- 
dent diabetes  mellitus  (NIDDM).  The basis for such de- 
fects  remain  unknown,  but  patients  with  NIDDM  have 
been found to have levels of GLUT-4 similar to those of 
normal individuals (Kahn, 1992). We have shown that the 
phenylalanine-based NH2-terminal and the COOH-termi- 
nal dileucine  motifs play important  and  distinct  roles in 
GLUT-4 targeting in the insulin-responsive 3T3-L1 adipo- 
cyte cell line. These findings may help lead to the identifi- 
cation of the protein  machinery that  facilitates  GLUT-4 
translocation and thus yield major insights into insulin ac- 
tion.  Further  studies  of  the  molecular  regulation  of 
GLUT-4 targeting are thus essential to elucidate the pre- 
cise mechanisms by which the amino and carboxy-terminal 
motifs function to regulate the targeting of GLUT-4.  Un- 
ravelling  the  exact  nature  of  these  regulatory  processes 
may provide a useful model with which to study a number 
of  other  important  proteins  that  recycle  between  the 
plasma membrane and intracellular loci, and to determine 
the extent to which signalling sequences may be conserved 
between such proteins. 
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